719919
Resomer® RG 752 H, Poly(D,L-lactide-co-glycolide)
acid terminated, lactide:glycolide 75:25, Mw 4,000-15,000
Synonym(s):
PLGA
About This Item
Recommended Products
form
(Powder or Solid or Chunk(s))
feed ratio
lactide:glycolide 75:25
mol wt
Mw 4,000-15,000
degradation timeframe
<6 months
impurities
≤0.1% Sulfated Ash (CONF0010 Conforms)
viscosity
0.14-0.22 dL/g, 0.5 % in chloroform(25 °C, Ubbelohde) (size 0c glass capillary viscometer)
transition temp
Tg 42-46 °C
storage temp.
2-8°C
InChI
1S/C6H8O4.C4H4O4/c1-3-5(7)10-4(2)6(8)9-3;5-3-1-7-4(6)2-8-3/h3-4H,1-2H3;1-2H2
InChI key
LCSKNASZPVZHEG-UHFFFAOYSA-N
Related Categories
General description
Legal Information
related product
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Articles
Interest in utilizing biodegradable polymers for biomedical applications has grown since the 1960s.
Synthetic aliphatic polyesters dominate resorbable biomaterials in clinical use.
AliAliphatic polyesters, including polylactide and polyglycolide, are biodegradable polymers widely used in medical applications.
Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service